Pharmacokinetics of tobramycin nebulizer solution (300mg/4ml) administered by Pari e-Flow rapid vs Pari LC plus nebulizer in patients with cystic fibrosis and Pseudomonas aeruginosa infection
Year: 2012
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: European Respiratory Journal
Institution: Chiesi (Italy)
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1834894137
